Medical equipment maker Agilent Technologies cut annual profit and sales forecasts for a second straight quarter as demand stays soft in major market China due to a slow economic recovery.
The Walt Disney Company (NYSE:DIS) is being sued by Hollywood financer TSG Entertainment for allegedly withholding millions of dollars worth of film profits.  The suit, filed Tuesday in Los Angeles S
Agilent Technologies (NYSE:A) Inc announced after Tuesday's close that its third-quarter 2023 revenue slipped 2.7% year over year to $1.67 billion but edged past the consensus estimate of $1.66 billio
U.S. equities advanced at midday on Monday, July 31, 2023, heading for a winning month on strong earnings and easing inflation.
RTX said some 200 engines will have to be removed from airline fleets for accelerated inspections.
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2023 after the stock market closes on Tuesday, Aug. 15. In
Agilent Technologies, a $35 billion leader in global life sciences, is trading 30% below its all-time high and 20% down year-to-date, presenting a potential growth/value opportunity. Despite challenge
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of th
A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates.
Agilent Technologies Inc. NYSE: A stock is underperforming the market, trading down 19% year-to-date. Agilent is a leading global provider of laboratory technologies and equipment.
Investors seeking growth often have no choice other than paying up for a stock with strong potential. However, there are some stocks that appear to be trading at low valuations relative to their growt
Agilent Technologies (A) expands InfinityLab GPC/SEC portfolio to cater well to the needs of scientists in the macromolecular analysis.
Agilent Technologies (A) strengthens its Life Sciences & Applied Markets Group (LSAG) segment with 6495 LC//TQ and Revident LC/Q-TOF.
Our 3-step process focuses on wide-moat stocks (as per Morningstar's rating). We are only interested in those targets that are attractively valued in historical comparison. We share the heat map of th
Agilent Technologies, Inc. stock has long traded at a premium valuation. The company has traditionally performed well, thanks to a solid positioning and continued M&A efforts.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE